These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38614264)

  • 1. Potential Mechanisms of Guizhi Fuling Wan in Treating Endometriosis: An Analysis Based on TCMSP and DisGeNET Databases.
    Yee JL; Huang CY; Yu YC; Huang SJ
    J Ethnopharmacol; 2024 Jul; 329():118190. PubMed ID: 38614264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatory effects of current regimens and Guizhi Fuling Wan on the development of endometriosis.
    Chen CC; Huang CY; Shiu LY; Yu YC; Lai JC; Chang CC; Fu CF; Huang SJ
    Taiwan J Obstet Gynecol; 2022 Jan; 61(1):70-74. PubMed ID: 35181049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Literature research and status analysis on clinical application of Guizhi Fuling Formula].
    Zhang W; Song DR; Lin KL; Wang XX; Wei L; Xing J
    Zhongguo Zhong Yao Za Zhi; 2020 Dec; 45(23):5789-5796. PubMed ID: 33496120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guizhi Fuling Wan reduces autophagy of granulosa cell in rats with polycystic ovary syndrome via restoring the PI3K/AKT/mTOR signaling pathway.
    Liu M; Zhu H; Zhu Y; Hu X
    J Ethnopharmacol; 2021 Apr; 270():113821. PubMed ID: 33460753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guizhi Fuling Formulation: A review on chemical constituents, quality control, pharmacokinetic studies, pharmacological properties, adverse reactions and clinical applications.
    Liu X; Chen L; Sun P; Zhan Z; Wang J
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117277. PubMed ID: 37802375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Main progress on studies of pharmacological activities and clinical applications of Guizhi Fuling capsule].
    Su ZZ; Li N; Cao L; Wang TJ; Zhang CF; Ding G; Wang ZZ; Xiao W
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):989-92. PubMed ID: 26226732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guizhi Fuling Wan attenuates tetrachloromethane-induced hepatic fibrosis in rats via PTEN/AKT/mTOR signaling pathway.
    Yao H; He Q; Xiang L; Liu S; Yang Z; Li X; Liu W; Huang C; Wang B; Xie Q; Gao Y; Zheng C; Li X
    J Ethnopharmacol; 2024 Nov; 334():118593. PubMed ID: 39032663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic pharmacological verification of Guizhi Fuling decoction in treating endometriosis-associated pain.
    Gao Y; Ji W; Lu M; Wang Z; Jia X; Wang D; Cao P; Hu C; Sun X; Wang Z
    J Ethnopharmacol; 2022 Oct; 297():115540. PubMed ID: 35870685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data mining in Xu Runsan's Traditional Chinese Medicine practice: treatment of chronic pelvic pain caused by pelvic inflammatory disease.
    Liu L; Yang F; Jing Y; Xin L
    J Tradit Chin Med; 2019 Jun; 39(3):440-450. PubMed ID: 32186017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of relationships among syndrome, therapeutic treatment, and Chinese herbal medicine in patients with coronary artery disease based on complex networks].
    Gao ZY; Zhang JC; Xu H; Shi DZ; Fu CG; Qu D; Zhou XZ
    Zhong Xi Yi Jie He Xue Bao; 2010 Mar; 8(3):238-43. PubMed ID: 20226145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traditional Chinese medicine prescription Guizhi Fuling Pills in the treatment of endometriosis.
    Wang X; Shi Y; Xu L; Wang Z; Wang Y; Shi W; Ma K
    Int J Med Sci; 2021; 18(11):2401-2408. PubMed ID: 33967618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of different forms of Guizhi Fuling Wan on reproduction and metabolism in women with polycystic ovary syndrome: A protocol for a meta-analysis of randomized controlled trials.
    Liu M; Zhu H; Hu X; Zhu Y; Chen H
    Medicine (Baltimore); 2020 Oct; 99(44):e22954. PubMed ID: 33126363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guizhi Fuling Wan, Chinese Herbal Medicine, Ameliorates Insulin Sensitivity in PCOS Model Rats With Insulin Resistance via Remodeling Intestinal Homeostasis.
    Zhu Y; Li Y; Liu M; Hu X; Zhu H
    Front Endocrinol (Lausanne); 2020; 11():575. PubMed ID: 32973686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder.
    Lu CC; Lin MY; Chen SY; Shen CH; Chen LG; Hsieh HY; Chan MW; Hsu CD
    BMC Complement Altern Med; 2013 Feb; 13():44. PubMed ID: 23433042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactive triterpenoid compounds of Poria cocos (Schw.) Wolf in the treatment of diabetic ulcers via regulating the PI3K-AKT signaling pathway.
    Ding X; Li S; Huang H; Shen J; Ding Y; Chen T; Ma L; Liu J; Lai Y; Chen B; Wang Y; Tan Q
    J Ethnopharmacol; 2024 May; 325():117812. PubMed ID: 38301984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A network pharmacology approach to investigate the pharmacological effects of Guizhi Fuling Wan on uterine fibroids.
    Zeng L; Yang K; Liu H; Zhang G
    Exp Ther Med; 2017 Nov; 14(5):4697-4710. PubMed ID: 29201170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized double-blind trial comparing low dose and conventional dose of a modified traditional herbal formula Guizhi Fuling Wan in women with symptomatic uterine fibroids.
    Meng W; Lin WL; Yeung WF; Zhang Y; Ng EHY; Lee YPE; Zhang ZJ; Rong J; Lao L
    J Ethnopharmacol; 2022 Jan; 283():114676. PubMed ID: 34562564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Guizhi Fuling Wan for primary dysmenorrhea: protocol for a randomized controlled trial.
    Du Y; Li Y; Fu X; Li C; Yanan L
    Trials; 2021 Dec; 22(1):933. PubMed ID: 34922588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research on Quality Markers of Guizhi Fuling Prescription for Endometriosis Treatment Based on Gray Correlation Analysis Strategy.
    Chen J; Gai X; Xu X; Liu Y; Ren T; Liu S; Ma T; Tian C; Liu C
    Front Pharmacol; 2020; 11():588549. PubMed ID: 33510637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming cisplatin resistance by targeting the MTDH-PTEN interaction in ovarian cancer with sera derived from rats exposed to Guizhi Fuling wan extract.
    Han L; Cao X; Chen Z; Guo X; Yang L; Zhou Y; Bian H
    BMC Complement Med Ther; 2020 Feb; 20(1):57. PubMed ID: 32066429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.